Satellite Symposia At AHNS 2016

These presentations are planned and presented by our corporate colleagues. Your attendance is encouraged.

Sunday, July 17, 2016

Medrobotics  |  6:30 am – 7:45 am  |  Room 4C3
Flexible Robotic Surgical System for Oropharynx, Hypopharynx and Larynx

The Flex® Robotic System is the world’s first commercially available flexible robotic surgery platform. Designed specifically for otolaryngology, the System allows surgeons to navigate around with anatomy with a flexible, shapeable robotic scope equipped with high-definition vision. Once positioned, the scope becomes rigid and allows the surgeon to operate with flexible instruments in hard-to-reach, confined spaces. Surgeons from around the world will discuss their experiences using the Flex® Robotic System for transoral procedures in the oropharynx, hypopharynx, and larynx.

Speakers: Dr. Umamaheswar Duvvari, Dr. David Goldenberg, Prof. Stephan Lang and Prof. Marc Remacle

Monday, July 18, 2016

Intuitive Surgical  |  6:00 am – 7:15 am  |  Room 4C2
Innovations in Robotic Surgery – Intuitive Breakfast Symposium – Dedicated to Technological Excellence

The latest invocations in TOS
Updates of robotic clinical trials
Upcoming Technology
Exclusive footage/Experiences from preclinical studies
Speakers: Drs. Chris Holsinger, Eric J. Moore and Gregory S. Weinstein

Medtronic  |  6:00 am – 7:15 am  |  Room 4C4
State-of-the-Art Neural Monitoring 2016

Gregory Randolph, MD, FACS, FACE Clair & John Bertucci Chair in Thyroid Surgical Oncology, Harvard Medical School; Richard J. Wong, MD, FACS Chief Surgeon Head & Neck, Memorial Sloan Kettering Cancer Center; and Catherine F. Sinclair, M.D., FRACS, Attending Surgeon Head & Neck Oncology, Mount Sinai West, New York, host a practical case management discussion.  A preview of the latest yet unpublished International Neural Monitoring Study Group’s latest guidelines is highlighted, along with C-IONM of the vagus nerve to detect signs of stress on the RLN, SLN nerve monitoring, and patient outcomes.  Audience members encouraged to bring their tough case questions for discussion.

Astra Zeneca  |  7:00 pm – 8:15 pm  |  Room 4C3
Overcoming Immune Evasion: Immune-Mediated Approaches in Oncology and Their Rationale in Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

This presentation will discuss how disruption of the regulatory pathways exploited by malignancies to evade an immune response is a promising investigational approach in many tumor types, including SCCHN. Increased understanding of the interactions across pathways has opened new avenues for expanding the potential of immune-mediated approaches. This presentation aims to educate on relevant immune pathways, the basis for combination approaches, and the rationale for an immune-mediated approach in SCCHN.

Speaker: Speaker:  Ezra Cohen, MD
Professor, Division of Hematology/Oncology,
Department of Medicine
Associate Director for Translational Science
UC San Diego Moores Cancer Center
Co-leader, Solid Tumor Therapeutics Program
San Diego, CA

Tuesday, July 19

Bristol-Myers Squibb  |  5:15 pm – 6:30 pm  |  Room 4C3
Immuno-Oncology: Emerging Research in Head and Neck Cancers

Review unmet needs in the current treatment landscape of H & N cancer
Provide an overview of the immune system’s role in SCC H & N cancer
Increase awareness around emerging research and immune-related targets in SCC H &N